These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 2222129)

  • 1. Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.
    Rickels K; Schweizer E; Case WG; Greenblatt DJ
    Arch Gen Psychiatry; 1990 Oct; 47(10):899-907. PubMed ID: 2222129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper.
    Schweizer E; Rickels K; Case WG; Greenblatt DJ
    Arch Gen Psychiatry; 1990 Oct; 47(10):908-15. PubMed ID: 2222130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment.
    Fontaine R; Chouinard G; Annable L
    Am J Psychiatry; 1984 Jul; 141(7):848-52. PubMed ID: 6145363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled discontinuation of benzodiazepine treatment for patients with panic disorder.
    Noyes R; Garvey MJ; Cook B; Suelzer M
    Am J Psychiatry; 1991 Apr; 148(4):517-23. PubMed ID: 2006699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term benzodiazepine users 3 years after participation in a discontinuation program.
    Rickels K; Case WG; Schweizer E; Garcia-Espana F; Fridman R
    Am J Psychiatry; 1991 Jun; 148(6):757-61. PubMed ID: 2035717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carbamazepine treatment in patients discontinuing long-term benzodiazepine therapy. Effects on withdrawal severity and outcome.
    Schweizer E; Rickels K; Case WG; Greenblatt DJ
    Arch Gen Psychiatry; 1991 May; 48(5):448-52. PubMed ID: 2021297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prior benzodiazepine exposure and benzodiazepine treatment outcome.
    Rickels K; Freeman EW
    J Clin Psychiatry; 2000 Jun; 61(6):409-13. PubMed ID: 10901337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone.
    Rickels K; Schweizer E; Csanalosi I; Case WG; Chung H
    Arch Gen Psychiatry; 1988 May; 45(5):444-50. PubMed ID: 2895993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential acute psychomotor and cognitive effects of diazepam on long-term benzodiazepine users.
    Gorenstein C; Bernik MA; Pompéia S
    Int Clin Psychopharmacol; 1994 Sep; 9(3):145-53. PubMed ID: 7814823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anxiety and depressive disorders in 4,425 long term benzodiazepine users in general practice].
    Pélissolo A; Maniere F; Boutges B; Allouche M; Richard-Berthe C; Corruble E
    Encephale; 2007; 33(1):32-8. PubMed ID: 17457292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders.
    Uhlenhuth EH; Balter MB; Ban TA; Yang K
    J Clin Psychopharmacol; 1999 Dec; 19(6 Suppl 2):23S-29S. PubMed ID: 10587281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Withdrawal reaction after long-term therapeutic use of benzodiazepines.
    Busto U; Sellers EM; Naranjo CA; Cappell H; Sanchez-Craig M; Sykora K
    N Engl J Med; 1986 Oct; 315(14):854-9. PubMed ID: 3092053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Withdrawal responses to abrupt discontinuation of desmethyldiazepam.
    Winokur A; Rickels K
    Am J Psychiatry; 1984 Nov; 141(11):1427-9. PubMed ID: 6437255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. III. Discontinuation effects.
    Pecknold JC; Swinson RP; Kuch K; Lewis CP
    Arch Gen Psychiatry; 1988 May; 45(5):429-36. PubMed ID: 3282479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-acting versus long-acting benzodiazepines: discontinuation effects in panic disorders.
    Burrows GD; Norman TR; Judd FK; Marriott PF
    J Psychiatr Res; 1990; 24 Suppl 2():65-72. PubMed ID: 1980701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A; Brunner H; Ising M; Pedrosa Gil F; Holsboer F; Friess E
    Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A therapeutic and discontinuation study of clobazam and diazepam in anxiety neurosis.
    Lapierre YD; Tremblay A; Gagnon A; Monpremier P; Berliss H; Oyewumi LK
    J Clin Psychiatry; 1982 Sep; 43(9):372-4. PubMed ID: 6126475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind, placebo-controlled trial of two doses of abecarnil for geriatric anxiety.
    Small GW; Bystritsky A
    J Clin Psychiatry; 1997; 58 Suppl 11():24-9. PubMed ID: 9363045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of personality on withdrawal severity and taper outcome in benzodiazepine dependent patients.
    Schweizer E; Rickels K; De Martinis N; Case G; García-España F
    Psychol Med; 1998 May; 28(3):713-20. PubMed ID: 9626727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.